Medical Device Daily: France Agrees to Test PneumRx Device
July 31, 2012 - Medical Device Daily
PneumRx (Mountain View, California), a maker of interventional pulmonary devices, said French Ministry
of Health has approved a cost-effectiveness study of the RePneu Lung Volume Reduction Coil (RePneu LVRC) in France. The Ministry of Health agreed to fund the study under the soutien aux techniques innovantes couteuses (STIC) program, which provides government funding for innovative medical technologies that have been validated by prior clinical studies, with a view toward establishing reimbursement for new devices.
The RePneu LVRC System is a minimally invasive device intended to improve lung function in emphysema patients by bronchoscopically implanting Nitinol coils into the lungs to compress diseased tissue (lung volume reduction), restore elastic recoil, and adjust lung compliance. This treatment offers a minimally invasive alternative to lung volume reduction surgery to a broad range of emphysema patients.
“We have seen tremendous improvement in most of the patients we have treated with the RePneu LVRC to date, and are confident that the patients we enroll in this STIC study will enjoy the same benefits, including increased exercise capacity, improved pulmonary function, and better quality of life,” said Gaetan Deslee, MD, principal investigator for the study.